Private Equity
Joining forces with Bales Nelson and Allen Dye, Waud will consider tech-enabled opportunities to invest behind the staffing needs of multiple end-markets, sites of care and customer bases.
3 min read · 09 April 2021
GHO Capital is buying Velocity Clinical Research and Clearlake extends holds with fund series.
3 min read · 08 April 2021
Covid has accelerated Velocity's growth plan by one to two years, while illustrating the clinical site organization's ability to efficiently ramp up operations, adapting to the needs of CROs and patients.
4 min read · 08 April 2021
A rush to acquire emboldened companies using cheap debt has increased purchase prices in a sellers’ market.
3 min read · 07 April 2021
Avista-backed United BioSource preps for sale and WindRose recaps Veristat.
2 min read · 07 April 2021
Avista, which recently closed its second healthcare-exclusive vehicle on $1.2bn, carved out UBC from Express Scripts in November 2017.
3 min read · 07 April 2021
The market continues to evolve, writes Mark Donnelly, managing director at Runway Growth Capital, who says he is seeing larger debt facilities, lower cost of capital, lighter covenants and less amortization.
3 min read · 06 April 2021
Partners plans to support the animal health compounding pharmacy with new product development, increased production at the company’s FDA-registered 503B Outsourcing Facility, among other things.
2 min read · 06 April 2021
Silversmith-backed Absorb Software goes on the block.
2 min read · 06 April 2021
The company, which has 'just finished' its management presentations, received strong interest from private equity firms, sources say.
2 min read · 06 April 2021
